Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. Ilyuk, V. Malenky (Vinnitsa, Ukraine). The clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia of the 3^rd group. Eur Respir J 2007; 30: Suppl. 51, 3277

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006 The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005 The general evaluation of community acquired pneumonia patients treated in our clinic Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004 Therapeutic regimens in community acquired pneumonia (CAP): association with patients characteristics and outcomes Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Clinical presentation and evolution of community acquired pneumonia in older patients Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Progress of quality indicator rates regarding treatment of patients hospitalized in Germany due to community acquired pneumonia (CAP) Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 The usage of laferon in treatment of patients with community acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007 Effect of a quality improvement plan on the outcome of patients with community acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 545s Year: 2003 The general evaluation of elderly patients with community acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004 The prognostic importance of plasma D-dimer levels in patients with community acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Viral and M. pneumoniae community acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Using roncoleukine in basic therapy of patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Health care associated pneumonia versus community acquired pneumonia: Comparison of etiology, treatment and prognosis Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Quality-indicators and prognostics in CAP in three populations Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 An RDW-based clinical model predicts long-term survival in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation multicentric study Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Validation of a computer predictive model to stratify risk and site of care in community acquired pneumonia (CAP) Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011